Maternal Alloimmunization Foundation

We had an amazing time at the FIGO World Congress of Gynecology and Obstetrics talking with health professionals from around the world about how they feel Maternal Alloimmunization Foundation can best work to support patients and families affected by #HDFN. We are looking forward to taking what we learned and implementing it into our future plans #FIGO23

We had an incredible third day at #FIGO23 meeting with heath professionals around the world and hearing their suggestions of how we can work together to support families affected by Hemolytic Disease of the Fetus and Newborn (HDFN). Come see us at booth NP10 for our last day in the exhibition hall.

We are so excited to be at FIGO's World Congress this week for the largest global event in gynaecology and obstetrics. We had a great time talking with health professionals and advocates all about Maternal Alloimmunization and HDFN and we are looking forward to the rest of the week at #FIGO23. Come meet us at booth NP10 to hear about how we are working to support families affected by HDFN!

We had a great time at Academy of Neonatal Nursing's Fall 2023 conference! Our team left filled with inspiration and an even deeper appreciation of all of the neonatal nurses and nurse practitioners we met throughout the week! Often, as the first healthcare professionals our babies interact with, they are a pivotal part of their care team and we were excited to have the opportunity to share who we are with them.

We are so excited to be at Academy of Neonatal Nursing's Fall 2023 National Neonatal and Advanced Practice Neonatal Nurses Conference to talk about Maternal Alloimmunization and Hemolytic Disease of the Fetus and Newborn! Come visit us tomorrow at booth 502!

We are so excited to see these Phase 2 results from Janssen! We believe that supporting advancing research is one of the main keys to improving patient outcomes for families affected by HDFN.

The Maternal Alloimmunization Foundation represents families around the world who are affected by small red blood cell antibodies. The antibodies cause hemolytic disease of the fetus and newborn (#HDFN). HDFN can cause anemia in an unborn baby that requires blood transfusions while still in the womb. If left untreated, HDFN can result in severe anemia, fetal hydrops, and even death. After birth, HDFN often causes dangerously high bilirubin levels (#jaundice) which can require a blood product made from thousands of donors, or an exchange transfusion to prevent brain damage and lifelong disability. The babies may also require several transfusions after birth for delayed onset anemia. Without these lifesaving transfusions babies with severe anemia can suffer lifelong effects or organ failure leading to death. Arielle has D and C antibodies and has had two pregnancies affected by HDFN. Her twins, Christian and Cason, were saved by blood donors 5 times after they were born. Arielle’s youngest child, Michaela, had 8 life saving intrauterine blood transfusions (IUTs). With the help of her maternal fetal medicine team at Tufts Medical Center, blood donors saved Michaela’s life 8 times before she was even born.  After birth Michaela went on to receive five life saving transfusions under the care of Boston Children's Hospital’s Department of Hematology. However, even with the most talented medical teams behind her, without blood donors Michaela would not be here. Please consider joining us at one of our blood drives found here: https://lnkd.in/eS9u9vrv to celebrate World Blood Donor Day throughout the month of June. A ten minute blood donation could be what saves the life of a baby like Michaela.